Maestros Electronics & Telecommun. Systems Ltd
Incorporated in 2010, Maestros Electronics & Telecommunications Systems Ltd is in the business of Electronics & Instrumentation (E&T) and Telemedicine[1]
- Market Cap ₹ 81.5 Cr.
- Current Price ₹ 148
- High / Low ₹ 182 / 60.0
- Stock P/E 18.7
- Book Value ₹ 55.4
- Dividend Yield 0.00 %
- ROCE 23.3 %
- ROE 17.6 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 235 to 172 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.3% over last 3 years.
- Earnings include an other income of Rs.1.97 Cr.
- Company has high debtors of 172 days.
- Promoter holding has decreased over last 3 years: -8.22%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10.23 | 14.30 | 16.54 | 11.04 | 12.86 | 9.22 | 9.53 | 13.54 | 47.55 | 11.15 | 24.60 | 33.29 | 31.91 | |
9.50 | 13.30 | 15.09 | 10.27 | 11.38 | 9.47 | 8.87 | 11.94 | 39.06 | 10.11 | 20.93 | 26.93 | 26.45 | |
Operating Profit | 0.73 | 1.00 | 1.45 | 0.77 | 1.48 | -0.25 | 0.66 | 1.60 | 8.49 | 1.04 | 3.67 | 6.36 | 5.46 |
OPM % | 7.14% | 6.99% | 8.77% | 6.97% | 11.51% | -2.71% | 6.93% | 11.82% | 17.85% | 9.33% | 14.92% | 19.10% | 17.11% |
0.08 | 0.39 | 0.55 | 0.84 | 0.52 | 0.82 | 0.58 | 0.47 | 0.96 | 1.48 | 1.26 | 1.80 | 1.97 | |
Interest | 0.12 | 0.32 | 0.42 | 0.32 | 0.37 | 0.33 | 0.31 | 1.10 | 1.37 | 0.46 | 0.52 | 0.80 | 0.84 |
Depreciation | 0.27 | 0.39 | 0.56 | 0.65 | 0.60 | 0.44 | 0.46 | 0.45 | 0.36 | 0.37 | 0.39 | 0.45 | 0.46 |
Profit before tax | 0.42 | 0.68 | 1.02 | 0.64 | 1.03 | -0.20 | 0.47 | 0.52 | 7.72 | 1.69 | 4.02 | 6.91 | 6.13 |
Tax % | 30.95% | 23.53% | 32.35% | 31.25% | 32.04% | 25.00% | 25.53% | 32.69% | 26.94% | 25.44% | 25.87% | 28.51% | |
0.29 | 0.52 | 0.69 | 0.45 | 0.70 | -0.25 | 0.34 | 0.35 | 5.64 | 1.25 | 2.98 | 4.94 | 4.37 | |
EPS in Rs | 0.88 | 1.59 | 1.88 | 1.13 | 1.62 | -0.53 | 0.69 | 0.67 | 10.24 | 2.27 | 5.41 | 8.97 | 7.93 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.04% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 28% |
3 Years: | -11% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 71% |
3 Years: | -4% |
TTM: | -1% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 20% |
3 Years: | 31% |
1 Year: | 139% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 14% |
3 Years: | 12% |
Last Year: | 18% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.28 | 3.28 | 3.68 | 3.97 | 4.31 | 4.71 | 4.94 | 5.24 | 5.51 | 5.51 | 5.51 | 5.51 |
Reserves | 4.55 | 5.07 | 5.97 | 6.91 | 7.79 | 8.24 | 9.02 | 9.94 | 16.08 | 17.05 | 20.06 | 25.02 |
4.27 | 3.53 | 3.99 | 2.59 | 3.88 | 2.61 | 2.56 | 8.23 | 2.10 | 2.10 | 4.79 | 5.35 | |
4.40 | 5.12 | 6.00 | 7.37 | 6.14 | 5.98 | 5.56 | 17.08 | 34.39 | 29.43 | 11.99 | 21.39 | |
Total Liabilities | 16.50 | 17.00 | 19.64 | 20.84 | 22.12 | 21.54 | 22.08 | 40.49 | 58.08 | 54.09 | 42.35 | 57.27 |
3.49 | 6.56 | 6.38 | 5.89 | 8.44 | 8.09 | 8.22 | 8.01 | 7.89 | 7.85 | 8.46 | 8.44 | |
CWIP | 2.31 | 0.00 | 1.36 | 2.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.48 |
Investments | 0.00 | 0.00 | 0.14 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
10.70 | 10.44 | 11.76 | 11.99 | 13.68 | 13.45 | 13.86 | 32.48 | 50.19 | 46.24 | 33.89 | 45.35 | |
Total Assets | 16.50 | 17.00 | 19.64 | 20.84 | 22.12 | 21.54 | 22.08 | 40.49 | 58.08 | 54.09 | 42.35 | 57.27 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.87 | 3.31 | 1.83 | 1.00 | -1.39 | -1.91 | -0.85 | -3.55 | 27.69 | -8.47 | -5.73 | 7.25 | |
-0.89 | -5.70 | -1.33 | -1.48 | 0.26 | 0.56 | 0.27 | 1.99 | 1.95 | 0.91 | -0.04 | -7.02 | |
1.92 | 0.09 | 0.63 | 0.47 | 0.68 | 0.47 | 0.23 | 2.09 | -4.50 | -0.74 | -0.57 | -0.24 | |
Net Cash Flow | 2.90 | -2.30 | 1.12 | -0.02 | -0.45 | -0.88 | -0.36 | 0.53 | 25.15 | -8.30 | -6.35 | -0.01 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 148.78 | 78.62 | 73.71 | 105.80 | 96.78 | 91.45 | 107.24 | 83.30 | 94.49 | 384.64 | 149.12 | 172.36 |
Inventory Days | 32.55 | 7.19 | 20.24 | 34.11 | 83.72 | 172.85 | 221.61 | 524.81 | 179.81 | 111.83 | ||
Days Payable | 130.77 | 113.16 | 137.12 | 309.85 | 199.24 | 318.37 | 221.61 | 153.48 | 137.38 | 73.40 | ||
Cash Conversion Cycle | 50.56 | -27.36 | -43.17 | -169.94 | -18.74 | -54.07 | 107.24 | 454.62 | 94.49 | 384.64 | 191.54 | 210.78 |
Working Capital Days | 26.40 | -24.76 | -32.88 | -82.98 | 2.84 | -5.94 | 58.22 | 234.26 | -123.13 | -220.31 | 72.41 | 22.26 |
ROCE % | 5.34% | 8.34% | 11.29% | 7.08% | 9.51% | 0.82% | 4.86% | 8.11% | 38.60% | 8.98% | 16.32% | 23.28% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
20 Jul - Copy of newspaper publication dated July 20, 2024 in the following newspaper with respect to Un- audited financial results for the quarter ended June 30, …
-
Announcement under Regulation 30 (LODR)-Acquisition
18 Jul - Incorporation of wholly owned subsidiary by way of investment up to Rs. 1,00,00,000/-, in one or more tranches.
- Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today I.E., July 18, 2024. 18 Jul
- Un-Audited Financial Results Along With Limited Review Report Of The Company For The Quarter Ended June 30, 2024. 18 Jul
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Jul - In accordance with Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended on June 30, 2024 and based on the certificate received from …
Business Overview:[1]
Company is a design, development and manufacturing company which creates
products and services for financial inclusion, cardiology, gynecology, critical care patient
and diseases management in medicine. It specializes in Medical device manufacturing, Telemedicine and Healthcare Solutions and Business Automation (Banking and Micro finance, financial inclusion, PDS automation)